Duke Industry Statistics Symposium 2019

 

Innovative Design and Analysis for Complex Clinical Trials for Drug and Device Developments

The Duke Annual Statistics Symposium (DISS) is organized by the Department of Biostatistics and Bioinformatics, Duke University School of Medicine, and co-sponsored by Boehringer-Ingelheim, ICSA, Janssen, NC-ASA Chapter, Parexel, PPD, IQVIA and SAS. It was established 6 years ago to discuss challenging issues and recent advances related to the clinical development of drugs and devices and to promote research and collaboration among statisticians from industry, academia, and regulatory agencies.

The theme for our next symposium in Spring, 2019 will be "Innovative Design and Analysis for Complex Clinical Trials for Drug and Device Developments.” The first day will include four short courses. The 2nd day will begin with a keynote by Dr. John Scott, Director for the Center for Biologics Evaluation and Research with the U.S. Food and Drug Administration on "Infoming Decision Making Through Innovative Trial Designs and Analysis" followed by parallel sessions.  On Friday morning , Dr. Scott Berry of Berry Consultants,LLC will give a keynote on "Innovating the Clinical Trial: Adaptive and Platform"  followed by the remainder of the parallel scientific sessions. A poster session will also be held.  Click here to learn more.